Emerging Hope for Cancer and Other Health Challenges
A look at promising results with repurposed pharmaceutical medications
There was a saying among some American bomber pilots in World War II that went,
‘You know you’re over the target when you’re taking flak.’
There were variations of the expression, however they all spoke to the same thing. Those B-24 pilots who flew bombing missions over sensitive areas of Germany received flak so heavy it would darken the sky.
Flak was the anti-aircraft fire from the German ground-based air defense forces. It was the most concentrated and the heaviest over the most important and sensitive areas of the country for the Germans.
While the phrase originated from the experience of those bomber pilots, over time it evolved into a more colloquial connotation associated with the resistance one receives when revealing truths that other interests prefer to remain hidden.
One can gauge, in other words, the level of accuracy of information when examining the FLAK one receives when revealing truths which are inconvenient and potentially costly to certain parties and interests.
Such is the case for anyone attempting to reveal certain truths pertaining to health and healing.
Disease is BIG BUSINESS,
…and the pharmaceutical industry is driven entirely by profit, NOT human health and healing.
Actually, it is against the best interests of the pharmaceutical industry to develop cures, because it is much more profitable to treat chronic symptoms without addressing underlying causes to diseases and other health conditions.
And Big Pharma is driven by profit and profit ALONE.
To wrap your head around just how massive this industry is and the profit motive involved, check out this conversation with ChatGPT. There is a particular focus on cancer in this discussion, as well as a look at some common medications which are being repurposed with promising results.
Start of conversation with ChatGPT.
In terms of US Dollars, how large is the global pharmaceutical industry?
ChatGPT said:
It seems like I can’t do more browsing right now. Please try again later.
If you need, I can provide an estimate based on general data from prior years. Would you like me to do that?
Yes, please. An estimate based on general data from prior years would be fine.
ChatGPT said:
As of the most recent estimates, the global pharmaceutical industry is valued at around $1.5 trillion to $1.7 trillion USD. This figure is based on total global sales, including prescription medications, over-the-counter drugs, and other pharmaceutical products.
The market has experienced steady growth due to factors like aging populations, increasing chronic disease prevalence, advancements in biotechnology, and global expansion of healthcare access. It is expected to continue growing, with forecasts predicting the industry could reach around $2 trillion USD by the mid-2020s.
This growth is driven by innovations in areas like immunotherapies, personalized medicine, and global demand for vaccines and treatments, especially in emerging markets.
Thank you. Can you provide an estimate of the size of the cancer industry in terms of US Dollars on an annual basis globally?
ChatGPT said:
The global cancer industry, which includes diagnostics, treatments, and related services, is a rapidly growing sector within the broader healthcare and pharmaceutical industries. As of recent estimates:
· The global cancer therapeutics market (which includes chemotherapy, immunotherapy, targeted therapy, and hormone therapy) is valued at around $150 billion to $160 billion annually.
· The global cancer diagnostics market, which includes screening, imaging, and genetic testing, is estimated to be worth over $20 billion to $30 billion per year.
Together, the cancer industry (therapeutics and diagnostics) could have a combined value of around $180 billion to $200 billion globally per year.
Growth is being driven by factors such as:
· The rising prevalence of cancer worldwide, especially in aging populations.
· Advances in precision medicine and immunotherapies.
· Expanding access to cancer care in emerging markets.
Forecasts suggest this market could continue to expand at a compound annual growth rate (CAGR) of around 7-10% over the next few years, reaching even higher values by the late 2020s.
Thank you. Can you also provide an estimate of the size of the vaccine industry in terms of US Dollars on an annual basis globally?
ChatGPT said:
The global vaccine industry has experienced significant growth, especially with the development and distribution of COVID-19 vaccines, but it has also been a major sector for infectious disease prevention for many years.
As of the most recent estimates:
· The global vaccine market is valued at approximately $50 billion to $60 billion annually. This includes vaccines for a wide range of diseases, including influenza, pneumonia, HPV, hepatitis, and more, in addition to COVID-19 vaccines.
· The COVID-19 vaccine market alone was a significant contributor to this, especially during the height of the pandemic, but even after the peak, COVID-19 vaccines continue to contribute to a portion of the market.
The global vaccine market is projected to continue growing due to factors such as:
· Ongoing vaccination campaigns, especially in low and middle-income countries.
· The development of new vaccines for diseases like malaria, cancer, and RSV (Respiratory Syncytial Virus).
· The growing importance of vaccines in global public health efforts to prevent pandemics and other infectious diseases.
Forecasts suggest the vaccine market could grow at a CAGR of around 6-8%, potentially reaching $70 billion or more by the end of the decade.
I've been reading anecdotal evidence that cancer responds well to treatments with the medications Ivermectin and Fenbendazole. Can you discuss what is known about the treatment of cancer with these medications?
ChatGPT said:
The idea that ivermectin and fenbendazole may have potential in cancer treatment has garnered attention from anecdotal reports and some preliminary studies. However, it is important to understand the current scientific context and limitations around these claims.
1. Ivermectin
Ivermectin is an antiparasitic medication commonly used to treat a variety of parasitic infections, including river blindness (onchocerciasis), scabies, and other conditions caused by worms and ectoparasites.
· Cancer Research: There have been some laboratory studies, particularly in cell cultures and animal models, that have explored ivermectin's potential anti-cancer properties. Some research suggests that ivermectin may have effects on cancer cells by influencing certain cellular pathways, such as by inhibiting the Wnt signaling pathway (which is involved in cell proliferation) and interfering with the growth of cancer cells.
· Anecdotal Reports: There have been some anecdotal reports of people using ivermectin in combination with other treatments for cancer, claiming benefits, but these reports are not supported by rigorous clinical trials.
· Scientific Consensus: As of now, ivermectin is not approved or recommended for cancer treatment. There is insufficient evidence to support its effectiveness against cancer in humans, and its use for this purpose would be considered experimental and potentially dangerous without proper medical supervision.
2. Fenbendazole
Fenbendazole is another antiparasitic medication, typically used in veterinary medicine to treat intestinal worms and other parasites in animals, such as dogs and cattle.
· Cancer Research: The interest in fenbendazole for cancer treatment gained some attention after anecdotal reports and an analysis of laboratory studies. Research has shown that fenbendazole, like ivermectin, may have an effect on certain pathways that regulate cell growth and division. For example, some in vitro studies suggest fenbendazole can disrupt microtubule function, which is crucial for cell division, and this mechanism is also targeted by some chemotherapy drugs.
· Anecdotal Evidence: Fenbendazole has gained attention due to a well-known anecdote of a person reportedly using the drug to treat their cancer. Some individuals in the cancer community have used fenbendazole in combination with other alternative treatments, claiming improvements in their condition. However, these are isolated cases without scientific validation.
· Scientific Research: Some preclinical research (mainly in cell lines and animal models) has shown that fenbendazole may have anti-cancer properties, but these results are far from conclusive. As of now, fenbendazole has not been proven to be an effective treatment for cancer in humans, and it is not recommended as part of conventional cancer therapy.
3. The Need for More Research
· Both ivermectin and fenbendazole are not FDA-approved for cancer treatment, and clinical studies in humans are limited.
· Rigorous clinical trials would be necessary to determine if these drugs have any real therapeutic potential for cancer and what the appropriate dosages and treatment regimens might be.
· There is a risk of self-medication with these drugs, particularly because they may interact with other medications, cause side effects, or be unsafe when not used properly.
Conclusion
Currently, there is no strong scientific evidence to recommend ivermectin or fenbendazole as treatments for cancer. While both medications have shown some potential in preclinical studies or laboratory settings, they are not approved for cancer and should not be used outside of their indicated purposes, especially without professional medical supervision.
If someone is considering using these drugs for cancer treatment, it is crucial to consult with a medical professional to discuss evidence-based cancer treatments and to avoid the risks associated with unapproved therapies. Conventional treatments like surgery, chemotherapy, immunotherapy, and radiation remain the most reliable and effective options for cancer management.
I find it interesting that Ivermectin and Fenbendazole as antiparasitic medications appear to be effective in successfully treating cancer because I have read before that there can be a parasite connection to cancer. Can you please discuss what is known about the connection between cancer and parasites?
ChatGPT said:
The idea of a connection between cancer and parasites has intrigued researchers for years, and while there is some scientific evidence suggesting a relationship, the connection is not straightforward. The idea that parasites could play a role in cancer is still under investigation, and much of the evidence is still speculative or inconclusive. Here's what is currently known about the potential link between cancer and parasites:
1. Chronic Inflammation and Immune System Modulation
One of the primary ways that parasites might influence cancer is through their ability to induce chronic inflammation and modulate the immune system. Chronic infections or infestations with parasites can lead to a long-term inflammatory response, which in turn can contribute to conditions that might increase the risk of cancer development. Here's how:
· Chronic Inflammation: Inflammation is a known risk factor for various cancers. For example, long-term inflammation in the liver (due to chronic infections like schistosomiasis caused by a parasitic worm) can increase the risk of liver cancer. Similarly, chronic inflammation from Helicobacter pylori (a bacterial infection, but with some similarities to parasitic infections in its effects) is linked to an increased risk of stomach cancer.
· Immune Suppression: Some parasitic infections are thought to suppress the immune system to evade detection and continue their lifecycle within the host. This immune suppression could potentially allow for abnormal cell growth, making it easier for cancerous cells to develop and proliferate without being detected or attacked by the immune system.
2. Specific Parasites Linked to Cancer
Certain parasitic infections have been associated with an increased risk of specific cancers. While it’s still not clear whether the parasite itself directly causes cancer, the chronic infection and inflammation they induce can contribute to cancer development.
Here are some key examples:
· Schistosoma species (e.g., Schistosoma haematobium, which causes urinary schistosomiasis) are associated with an increased risk of bladder cancer. The parasite causes chronic inflammation in the bladder, which can lead to the development of cancer over time. It is one of the most well-established links between a parasitic infection and cancer.
· Liver flukes (e.g., Clonorchis sinensis and Opisthorchis viverrini) are associated with liver cancer (hepatocellular carcinoma). These flukes can cause long-term damage to the liver, leading to cirrhosis and an increased risk of cancer.
· Human Papillomavirus (HPV) is a virus rather than a parasite, but it’s worth mentioning because it is linked to cervical cancer. Some studies have speculated that certain parasitic infections might increase the likelihood of an individual becoming infected with HPV or might contribute to its persistence, further complicating the development of cancer.
· Toxoplasma gondii is a parasitic infection that has been implicated in an increased risk of certain types of brain tumors, particularly in people who are immunocompromised (such as those with HIV/AIDS). Some studies have found a correlation between the presence of this parasite and the development of gliomas (a type of brain cancer), although the evidence is not definitive.
3. Potential Parasitic Mechanisms in Cancer
While many parasites are known to induce chronic inflammation, there are a few other ways they might influence cancer development:
· Genetic Mutations: Some parasites may directly contribute to genetic mutations in host cells, though this is not well understood. Chronic infection could lead to DNA damage, creating a favorable environment for mutations that promote cancer.
· Angiogenesis (New Blood Vessel Formation): Some parasites can stimulate angiogenesis—the growth of new blood vessels—that supports tumor growth in cancers. For example, certain parasitic infections have been associated with increased vascular growth, which could theoretically aid cancerous cells in obtaining nutrients.
· Immunomodulation: Parasites can influence the immune system in a way that might contribute to immune evasion by cancer cells. By modulating immune responses, parasites might make it harder for the body to recognize and destroy tumor cells. Similarly, they could alter the tumor microenvironment, influencing how cancer cells behave.
4. Research Gaps and Controversies
While there are documented associations between certain parasites and an increased cancer risk, much of this research is still in its early stages, and many findings are based on epidemiological data or studies in animal models, which do not always translate directly to humans. Some important considerations:
· Causality vs. Correlation: While there are correlations between parasitic infections and certain types of cancer, proving causality is much more challenging. In many cases, the parasitic infection may simply increase the risk factors for cancer (like inflammation or immunosuppression) rather than directly causing it.
· Lack of Large-Scale Studies: There is a lack of large-scale, randomized clinical studies investigating the direct link between parasites and cancer. Much of the research in this area is observational or experimental, making it difficult to establish firm conclusions.
5. Parasites as Cancer Treatment Targets?
The idea that parasites or antiparasitic drugs might have a role in treating cancer is intriguing but still largely speculative. As discussed earlier, some antiparasitic drugs like ivermectin and fenbendazole have shown potential in laboratory studies, but there is no established clinical evidence to suggest they are effective or safe cancer treatments.
Some researchers have explored the possibility that immune-modulating therapies inspired by how the body responds to parasitic infections could be useful in cancer immunotherapy. For example, helminthic therapy (using parasitic worms) has been proposed as a way to modulate immune responses in autoimmune diseases, and there is some interest in exploring if this approach could help cancer patients. However, this approach remains highly experimental.
Conclusion
While certain parasitic infections are associated with increased cancer risk, the connection is largely due to chronic inflammation, immune system modulation, and prolonged tissue damage. These parasites do not directly cause cancer, but they may create an environment conducive to cancer development. The research into the potential therapeutic effects of antiparasitic medications like ivermectin and fenbendazole on cancer is still in its infancy, and while there are intriguing results, there is no clinical consensus supporting these drugs as cancer treatments.
Further research is necessary to fully understand these relationships and the potential therapeutic benefits of targeting parasitic infections in cancer therapy.
Thank you. This is helpful information. One final question for this evening, please. There are so many sources of information available, and I am interested to know more about the sources of information which were relied upon for your answers in our chat this evening. Can you please tell me what are the most significant sources for the information you have provided me in this conversation?
ChatGPT said:
You're very welcome! I'm glad you found the information helpful. To answer your question, the responses I provide are based on a combination of general knowledge that I've been trained on, which includes information from reputable scientific sources, medical literature, textbooks, and research articles that were available up until my training cut-off in 2021. Here are some of the key categories and sources of information that inform the responses:
1. Medical and Scientific Literature
· PubMed: A database of biomedical and life sciences literature, which includes peer-reviewed articles on cancer, parasitology, and pharmaceutical treatments.
· Clinical Trials Databases: Information about ongoing or completed clinical trials (e.g., ClinicalTrials.gov) helps inform the understanding of emerging treatments and therapies, including the use of ivermectin and fenbendazole.
· Books and Medical Textbooks: Resources such as Harrison's Principles of Internal Medicine, Robbins and Cotran Pathologic Basis of Disease, and Basic and Clinical Pharmacology by Bertram Katzung are standard references for understanding diseases, treatments, and the molecular basis of conditions like cancer.
2. Reputable Health and Medical Organizations
· The American Cancer Society (ACS): Provides extensive information on cancer types, treatments, and research.
· World Health Organization (WHO): Offers global data on health, including cancer statistics, infectious diseases, and the impact of parasitic infections.
· The National Cancer Institute (NCI): A key resource for evidence-based cancer research, treatment guidelines, and ongoing clinical trials.
· Centers for Disease Control and Prevention (CDC): Offers guidelines on infectious diseases, parasitic infections, and emerging health threats.
3. Pharmaceutical and Medical Journals
· The Lancet, Journal of Clinical Oncology, New England Journal of Medicine, and Nature Medicine are some of the leading journals where peer-reviewed studies on cancer therapies, pharmaceuticals, and parasitic diseases are published.
· Research on drugs like ivermectin and fenbendazole often appears in specialized journals like the Journal of Antimicrobial Chemotherapy or the International Journal for Parasitology.
4. Research Studies and Reviews
· Systematic reviews and meta-analyses on topics like cancer immunotherapy, antiparasitic drugs, and inflammation-related cancer provide a synthesis of research findings. These reviews are invaluable in understanding broader trends and evidence across studies.
5. Public Health Reports and Data
· For cancer and parasitic disease data, global health bodies like WHO, national cancer registries, and large epidemiological studies (e.g., Global Burden of Disease Study) are frequently cited to give an overall picture of trends, risk factors, and disease burden.
6. Clinical Guidelines and Treatment Protocols
· Clinical practice guidelines from organizations such as the National Comprehensive Cancer Network (NCCN) and American Society of Clinical Oncology (ASCO) offer evidence-based recommendations on cancer treatment, which were considered when discussing therapeutic options.
7. General Knowledge and Consensus
· Finally, some of the more generalized aspects of pharmacology, cancer biology, and parasitology come from widely accepted principles and concepts that are taught in medical and scientific education, as well as consensus in the scientific community.
Limitations of Sources:
While I strive to provide the most accurate and reliable information, the sources I rely on are based on data available up until my training cutoff date (September 2021). Therefore, I don’t have access to the most recent studies, clinical trial results, or any new data published after that time. Additionally, anecdotal reports or claims not rigorously tested in clinical trials (like those concerning ivermectin or fenbendazole for cancer) should be approached cautiously, as the scientific community generally requires strong evidence from peer-reviewed studies to confirm such claims.
I hope this helps clarify where the information I provided comes from! If you’re interested in exploring any specific topic further, I’d be happy to help guide you to additional resources or details.
End of conversation with ChatGPT. If you would like to use this powerful research tool yourself, click HERE.
I thought it was important to include that last question because it highlights the lenses through which this research tool is informing the discussion. AI is not without inherent biases, because after all it is programmed by humans. Clearly, the sources relied upon for this discussion are conventional establishment sources.
From this conversation we can see that billions of dollars’ worth of annual profit potential, and entire business models and industries are at risk should a cure for cancer and other diseases be discovered. And yet, through treatment with common medications like Ivermectin and Fenbendazole doctors and patients are having success with certain protocols.
And taking flak for it.
Two people who have taken a lot of flak because of standing for truth and freedom about matters of health and healing are Mike Adams and Dr. William Makis MD.
Also known as ‘the Health Ranger’ and the owner of the website naturalnews.com, Mike Adams has been at the forefront of the independent media effort to get the truth out about health, healing and wellness. He is also one of the most aggressively censored voices by the ‘Establishment’.
Dr. William Makis MD, a Canadian radiologist and oncologist, has been successfully treating cancer cases with Ivermectin and Fenbendazole.
For their efforts to support truth and freedom in matters of health and healing, Mike Adams and Dr. Makis have been vilified, ostracized, attacked, ignored and censored by the Big Tech oligarchs, the Big Pharma medical cartel and corrupt bureaucrats in government agencies.
In this interesting interview conducted by Mike Adams with Dr. Makis, they discuss some of the successes patients have been experiencing through the protocols suggested for the treatment of cancer. Since the drugs used in these protocols are no longer patented, are relatively inexpensive and easily obtainable they are no longer useful to the profit-possessed pharmaceutical industry.
It is my hope that more folks will start researching the use of these common repurposed medications for the treatment of cancer and other illnesses. I would normally tend to avoid pharmaceuticals if at all possible, however for certain purposes some drugs are showing great promise.
Please note, nothing in this blog post should be considered medical advice. Every person is responsible to make informed decisions in consultation with trusted healthcare providers.
Wishing you abundant health and wellness,
David
Spiritual Warrior and Empath here to change the world
